| 13:15-13:20 | Opening Remarks
Alan Cherrington, USA |
| 13:20–13:32 | Small Intestine Hyperplasia, Hormonal Consequences and Insulin Resistance
Filip Knop, Denmark |
| 13:32–13:45 | Metabolic Surgery for Type 2 Diabetes – Significance of Duodenal Exclusion
Carel LeRoux, Ireland |
| 13:45–13:57 | Duodenal Mucosal Resurfacing: Concept Overview and First In Human Results
Manoel Galvao, Brazil |
| 13:57–14:10 | REVITA 1 – A European Multi-Center Randomized Control Trial –Study Overview
Geltrude Mingrone, UK |
| 14:10–14:15 | Summary
Alan Cherrington, USA; K. George Alberti, UK; Francesco Rubino, UK |
INDUSTRY SESSION PROVIDED BY INTERNATIONAL MEDICAL PRESS AND SUPPORTED BY AN EDUCATIONAL GRANT BY NOVONORDISK
Non-surgical Weight Control in Type 2 Diabetes. What Works?
15:30-17:00
Hall B
Chair: Nicholas Finer, UK
| 15:30-15:35 | Introduction
Nicholas Finer, UK |
| 15:35-15:55 | How does medical weight loss ameliorate type 2 diabetes
Mike Lean, UK |
| 15:55-16:15 | Newer pharmacotherapies for diabetes and weight loss
Clifford Bailey, UK |
| 16:15-16:35 | Integrating pharmacological weight control in multi-component management of type 2 diabetes
Luc Van Gaal, Belgium |
| 16:35-16:55 | Which intervention for which patient?
All Faculty |
| 16:55-17:00 | Summary and Closing Remarks
Nicholas Finer, UK |
Please visit our website for more information on this symposium:
SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM NOVONORDISK
The Science Behind Metabolic Surgery
The Mechanisms of Action of Metabolic Surgery
17:15-19:45
Hall B
Co-Chairs: Rachel Batterham, UK; John Kirwan, USA
SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM ETHICON
Diabetes Surgery - Cost Effectiveness, Coverage and Access to Care
(By invitation only)
17:15-19:45
Hall C
Chairs: William Herman, USA
INDUSTRY SESSION ORGANIZED BY METACURE
Diamond® by MetaCure: Minimally Invasive Treatment for Type 2 Diabetes by Electrical Modulation of Physiological Regulatory Systems
19:45-20:45
Hall B
Chair: Harold Lebovitz, USA
Electrophysiology of the stomach and principles of Gastric Contractility Modulation (GCM)
Shlomo Ben-Haim, UK |
| Surgical intervention in Diamond therapy Wieslaw Tarnowski, Poland |
| Clinical results of Diamond therapy for DM2T with obesity Harold Lebovitz, USA |
INDUSTRY SESSION ORGANIZED BY ETHICON
Ethicon Policy Symposium
The fight for patient access to care is constantly changing. The objective of the session is to identify the barriers that patients have in gaining access to surgery for the treatment of Obesity & Type 2 Diabetes.
19:45-20:15
Hall C
Featuring Dame Jenni Murray,
UK Coffee, refreshments & snacks will be available
WCITT2D Session 6: Policy Track
Cost-effectiveness of Diabetes Surgery and Heath Care Policies
10:20-12:40
Hall A
Co-Chairs: Bruce Wolfe, USA; K. George Alberti, UK
